Samir EL Andaloussi
Papers
1
Total Citations
2
H-Index
1
About
Samir EL Andaloussi is a pioneering figure in the field of oligonucleotide therapeutics and drug delivery, with a particular focus on extracellular vesicles and lipid-based nanoparticles. His major contributions center on developing novel strategies for the targeted delivery of nucleic acids, including siRNA and mRNA, to treat genetic diseases. He is widely recognized for his work on harnessing exosomes as natural delivery vehicles, demonstrating their potential to transport therapeutic cargo across biological barriers. EL Andaloussi has also advanced the understanding of cellular uptake mechanisms and endosomal escape, critical bottlenecks in nucleic acid therapy. With over 20,000 citations, his research has profoundly shaped the landscape of non-viral gene therapy. Notably, he co-founded Evox Therapeutics, a company translating exosome-based delivery into clinical applications, and his work has been instrumental in bringing oligonucleotide therapies closer to clinical reality. His contributions continue to inspire a new generation of researchers in nanomedicine and molecular therapeutics.
Research Focus
Key Achievements
Top Papers
- 1